STEM-12. TARGETING GLIOBLASTOMA WITH A BRAIN PENETRANT DRUG THAT IMPAIRS BRAIN TUMOUR STEM CELLS

Abstract

Abstract Brain tumour stem cells (BTSCs) are a population of self-renewing malignant stem cells that play an important role in glioblastoma tumour hierarchy and contribute to tumour growth, therapeutic resistance, and tumour relapse. Thus, targeting of BTSCs within the bulk of tumours represents a crucial therapeutic strategy. Here, we report a potent brain penetrant drug (AJ5939) that impairs BTSCs and impedes glioblastoma progression. We show that AJ5939 inhibits the self-renewal and growth of BTSCs harbouring a diverse range of oncogenic mutations without affecting non-oncogenic neural stem cells. Global gene expression profiling revealed significant alterations in BTSC transcriptome and attenuation of the expression of a large panel of genes involved in cell cycle progression, stemness, and DNA repair mechanisms. Mechanistically, we show that AJ5939 impairs Notch signalling pathway via directly targeting this pathway and altering the stemness signature. In combination with ionizing radiation (IR), however, AJ5939 suppresses the DNA repair mechanisms and facilitate the response of the BTSC to ionizing radiation induced cell death. Finally, we present data that AJ5939 treatment of brain tumours in preclinical models significantly prolongs lifespan.